Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Construction Begins On Georgia BioScience Training Center Near Atlanta, Georgia

03/31/2014
Construction has begun on the Georgia BioScience Training Center, east of Atlanta, Georgia, which is designed to support training for Baxter International Inc. employees and new companies in the life sciences industry that choose to locate in the Peachtree State.

The training center is located across from Baxter’s $1 billion biomanufacturing plant. Georgia Quick Start, a division within the Technical College System of Georgia, will operate the 52,000-square-foot facility. At the training center, Georgia Quick Start will provide customized workforce training for Baxter employees.

“This training facility represents not only our commitment to supporting Baxter’s needs, but also our commitment to growing the life sciences industry in Georgia,” said Governor Nathan Deal. “It’s projects like these that have made, and will continue to make, Georgia the No. 1 state in the nation in which to do business.”

“This Georgia BioScience Training Center will give us one of the most effective tools we can have in economic development to recruit more life science and health IT companies to Georgia,” said Georgia Department of Economic Development Commissioner Chris Carr. “The facility is designated solely to providing customized workforce training as an incentive to attract new biotech jobs to Georgia.”

“Preparing the workforce for the sophisticated, biological manufacturing processes involved in producing today’s therapies is a great challenge,” said Technical College System of Georgia Commissioner Ron Jackson. “These treatments save and benefit the lives of patients every day, and the training delivered at this center will support Baxter’s overall ability to serve patients.”

Exclusive Research